Discussion on the vital role of M&A in bringing the next generation of biopharmaceutical breakthroughs to patients.
Featured guests include:
Dr. Robert Kulick, Director, NERA Economic Consulting (moderator)
John Stanford, Executive Director, Incubate (speaker)
Mary Lehner, Partner, Freshfields Bruckhaus Deringer (speaker)
Tyler Morris, Director of Capital Development, Biocom California (speaker)
Comentarios